Evidence map›Paper›PMID 37143937›Full record

ArticleFrontiers in oncology2023

Papillary renal neoplasm with reverse polarity: A case report.

Chengjuan Xing, Hui Tian, Yunkun Zhang, Li Zhang, Jixia Kong

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Chengjuan XingDepartment of Pathology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Hui TianDepartment of Emergency Medicine, Dalian Municipal Central Hospital Affiliated of Dalian University of Technology, Dalian, China.
Yunkun ZhangDepartment of Pathology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Li ZhangDepartment of Pathology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Jixia KongDepartment of Pathology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Second Affiliated Hospital of Dalian Medical University · CNDalian Medical University · CNDalian University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a recently named rare renal tumor of epithelial origin, papillary renal neoplasm with reverse polarity (PRNRP) has unique histomorphological features and immunophenotypes, often associated with KRAS mutations and showing indolent biological behavior. In this study, we report a case of PRNRP. In this report, nearly all tumor cells were positive for GATA-3, KRT7, EMA, E-Cadherin, Ksp-Cadherin, 34βE12, and AMACR in varying intensities, focally positive for CD10 and Vimentin, while negative for CD117, TFE3, RCC, and CAIX.

Indexed as

case reportGATA3indolentKRASpapillary renal neoplasm with reverse polarity

Identifiers

PMID37143937
PMCPMC10151571
OpenAlexW4366291945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.